a2 Milk FY profit rises on strong China demand

Published 18/08/2025, 02:18
© Reuters.

Investing.com-- A2 Milk Company Ltd (NZ:ATM) clocked a 21% jump in its annual profit on Monday, aided by strong demand for infant formula in top market China, with the company also announcing the purchase of a new manufacturing facility.

The New Zealand infant milk formula maker posted an annual net profit attributable of NZ$202.9 million, up 21% from last year and also above Reuters estimates of NZ$202.2 million.

Sales grew 13.5% to a record high of NZ$1.90 billion. 

Australian and New Zealand shares of the firm rose about 1% in morning trade.

A2 Milk’s robust earnings came chiefly from strong infant formula demand in China, which is the company’s biggest market. Total infant formula sales jumped 10% in the year.

The company forecast flat net profit for the current fiscal year, and said operating margins will improve slightly to between 15% and 16% from 14.4% for fiscal 2025. 

A2 Milk said it will buy a nutritional manufacturing facility in New Zealand for NZ$282 million from China Mengniu Dairy.

The facility already has two existing China label product registrations, and is expected to further increase supplies to a2 Milk’s biggest market. 

The company also announced plans to divest its 75% stake in Mataura Valley Milk for about NZ$100 million. 

A2 Milk declared a final dividend of 11.5 NZ cents per share, and said it could declare a special dividend totalling NZ$300 million if its Mataura sale and its Mengniu acquisition go through.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.